1
|
Pote S, Kachhap S, Mank NJ, Daneshian L, Klapper V, Pye S, Arnette AK, Shimizu LS, Borowski T, Chruszcz M. Comparative structural and mechanistic studies of 4-hydroxy-tetrahydrodipicolinate reductases from Mycobacterium tuberculosis and Vibrio vulnificus. Biochim Biophys Acta Gen Subj 2020; 1865:129750. [PMID: 32980502 DOI: 10.1016/j.bbagen.2020.129750] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 09/20/2020] [Accepted: 09/21/2020] [Indexed: 10/23/2022]
Abstract
BACKGROUND The products of the lysine biosynthesis pathway, meso-diaminopimelate and lysine, are essential for bacterial survival. This paper focuses on the structural and mechanistic characterization of 4-hydroxy-tetrahydrodipicolinate reductase (DapB), which is one of the enzymes from the lysine biosynthesis pathway. DapB catalyzes the conversion of (2S, 4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate (HTPA) to 2,3,4,5-tetrahydrodipicolinate in an NADH/NADPH dependent reaction. Genes coding for DapBs were identified as essential for many pathogenic bacteria, and therefore DapB is an interesting new target for the development of antibiotics. METHODS We have combined experimental and computational approaches to provide novel insights into mechanism of the DapB catalyzed reaction. RESULTS Structures of DapBs originating from Mycobacterium tuberculosis and Vibrio vulnificus in complexes with NAD+, NADP+, as well as with inhibitors, were determined and described. The structures determined by us, as well as currently available structures of DapBs from other bacterial species, were compared and used to elucidate a mechanism of reaction catalyzed by this group of enzymes. Several different computational methods were used to provide a detailed description of a plausible reaction mechanism. CONCLUSIONS This is the first report presenting the detailed mechanism of reaction catalyzed by DapB. GENERAL SIGNIFICANCE Structural data in combination with information on the reaction mechanism provide a background for development of DapB inhibitors, including transition-state analogues.
Collapse
Affiliation(s)
- Swanandi Pote
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Sangita Kachhap
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland
| | - Nicholas J Mank
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Leily Daneshian
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Vincent Klapper
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Sarah Pye
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Amy K Arnette
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Linda S Shimizu
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA
| | - Tomasz Borowski
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, 30-239 Krakow, Poland
| | - Maksymilian Chruszcz
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA.
| |
Collapse
|
2
|
Qin W, Xie SX, Zhang J, Zhao D, He CX, Li HJ, Xing L, Li PQ, Jin X, Yin DC, Cao HL. An Analysis on Commercial Screening Kits and Chemical Components in Biomacromolecular Crystallization Screening. CRYSTAL RESEARCH AND TECHNOLOGY 2019. [DOI: 10.1002/crat.201900076] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- Wei Qin
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Si-Xiao Xie
- Key Laboratory for Space Bioscience & Biotechnology; School of Life Sciences, Northwestern Polytechnical University; Xi'an 710072 P. R. China
| | - Jie Zhang
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Dong Zhao
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Chun-Xia He
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Hui-Jin Li
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Lu Xing
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Peng-Quan Li
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Xi Jin
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| | - Da-Chuan Yin
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
- Key Laboratory for Space Bioscience & Biotechnology; School of Life Sciences, Northwestern Polytechnical University; Xi'an 710072 P. R. China
| | - Hui-Ling Cao
- Shaanxi Key Laboratory of Ischemic Cardiovascular Disease; Shaanxi Key Laboratory of Brain Disorders; Institute of Basic and Translational Medicine; Xi'an Medical University; Xi'an 710021 P. R. China
| |
Collapse
|
3
|
Lee CW, Park SH, Lee SG, Park HH, Kim HJ, Park H, Park H, Lee JH. Crystal structure of dihydrodipicolinate reductase (PaDHDPR) from Paenisporosarcina sp. TG-14: structural basis for NADPH preference as a cofactor. Sci Rep 2018; 8:7936. [PMID: 29786696 PMCID: PMC5962572 DOI: 10.1038/s41598-018-26291-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Accepted: 05/04/2018] [Indexed: 11/09/2022] Open
Abstract
Dihydrodipicolinate reductase (DHDPR) is a key enzyme in the diaminopimelate- and lysine-synthesis pathways that reduces DHDP to tetrahydrodipicolinate. Although DHDPR uses both NADPH and NADH as a cofactor, the structural basis for cofactor specificity and preference remains unclear. Here, we report that Paenisporosarcina sp. TG-14 PaDHDPR has a strong preference for NADPH over NADH, as determined by isothermal titration calorimetry and enzymatic activity assays. We determined the crystal structures of PaDHDPR alone, with its competitive inhibitor (dipicolinate), and the ternary complex of the enzyme with dipicolinate and NADPH, with results showing that only the ternary complex had a fully closed conformation and suggesting that binding of both substrate and nucleotide cofactor is required for enzymatic activity. Moreover, NADPH binding induced local conformational changes in the N-terminal long loop (residues 34–59) of PaDHDPR, as the His35 and Lys36 residues in this loop interacted with the 2′-phosphate group of NADPH, possibly accounting for the strong preference of PaDHDPR for NADPH. Mutation of these residues revealed reduced NADPH binding and enzymatic activity, confirming their importance in NADPH binding. These findings provide insight into the mechanism of action and cofactor selectivity of this important bacterial enzyme.
Collapse
Affiliation(s)
- Chang Woo Lee
- Unit of Polar Genomics, Korea Polar Research Institute, Incheon, 21990, Republic of Korea.,Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea
| | - Sun-Ha Park
- Unit of Polar Genomics, Korea Polar Research Institute, Incheon, 21990, Republic of Korea
| | - Sung Gu Lee
- Unit of Polar Genomics, Korea Polar Research Institute, Incheon, 21990, Republic of Korea.,Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea
| | - Hyun Ho Park
- College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak, Seoul, 06974, Republic of Korea
| | - Hak Jun Kim
- Department of Chemistry, Pukyong National University, 45 Yongso-ro, Busan, 48513, Republic of Korea
| | - HaJeung Park
- X-Ray Core, TRI, The Scripps Research Institute, Jupiter, FL, 33458, USA
| | - Hyun Park
- Unit of Polar Genomics, Korea Polar Research Institute, Incheon, 21990, Republic of Korea.,Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea
| | - Jun Hyuck Lee
- Unit of Polar Genomics, Korea Polar Research Institute, Incheon, 21990, Republic of Korea. .,Department of Polar Sciences, University of Science and Technology, Incheon, 21990, Republic of Korea.
| |
Collapse
|